MedTrace Logo

Memokath® 044TW Stent for Treatment of Urethral Stricture

NCT00270504 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2009-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate if the placement of a temporary urethral stent for up to 12 months, following dilation or internal urethrotomy (cutting open), results in a higher rate of urethral patency during the first year of follow-up when compared to the control group that does not receive a stent.

Conditions

  • Urethral Stricture

Interventions

DEVICE

Memokath stenting

Urethral Stenting

Sponsors & Collaborators

  • Pnn Medical DK

    lead INDUSTRY

Principal Investigators

  • Gerry Jordan, MD · Sentara/Engineers and Doctors

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2009-10-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00270504 on ClinicalTrials.gov